Department of Neuroradiology, Charité, Augustenburger Platz 1, 13353, Berlin, Germany.
Department of Nuclear Medicine, Charité, Augustenburger Platz 1, 13353, Berlin, Germany.
Sci Rep. 2021 Apr 27;11(1):9064. doi: 10.1038/s41598-021-87866-9.
To evaluate the diagnostic performance of magnetic resonance imaging (MRI) alone in comparison to positron emission tomography/ magnetic resonance imaging (PET/MRI) in patients with meningiomas. 57 patients with a total of 112 meningiomas of the brain were included. PET/MRI, including a fully diagnostic contrast enhanced MRI and PET, were acquired. PET/MRI was used as reference standard. The size and location of meningiomas was recorded. Likelihood-ratio chi-square tests were used to calculate p-values within logistic regression in order to compare different models. A multi-level logistic regression was applied to comply the hierarchical data structure. Multi-level regression adjusts for clustering in data was performed. The majority (n = 103) of meningiomas could be identified based on standard MRI sequences compared to PET/MRI. MRI alone achieved a sensitivity of 95% (95% CI 0.78, 0.99) and specificity of 88% (95% CI 0.58, 0.98). Based on intensity of contrast medium uptake, 97 meningiomas could be diagnosed with intense uptake (93.75%). Sensitivity was lowest with 74% for meningiomas < 0.5 cm, high with 95% for meningiomas > 2cm and highest with 100% for meningiomas 0.5-1.0 cm. Petroclival meningiomas showed lowest sensitivity with 88% compared to sphenoidal meningiomas with 94% and orbital meningiomas with 100%. Specificity of meningioma diagnostic with MRI was high with 100% for sphenoidal and hemispherical-dural meningiomas and meningiomas with 0.5-1.0 and 1.0-2.0 cm. Overall MRI enables reliable detection of meningiomas compared to PET/MRI. PET/MRI imaging offers highest sensitivity and specificity for small or difficult located meningiomas.
评估磁共振成像(MRI)单独用于脑脑膜瘤患者与正电子发射断层扫描/磁共振成像(PET/MRI)比较的诊断性能。共纳入 57 例、总计 112 例脑脑膜瘤患者。采集了 PET/MRI,包括全面的诊断性对比增强 MRI 和 PET。以 PET/MRI 为参考标准。记录脑膜瘤的大小和位置。采用似然比卡方检验在逻辑回归中计算 p 值,以比较不同模型。应用多级逻辑回归来符合层次数据结构。对数据进行聚类的多级回归调整。与 PET/MRI 相比,大多数(n = 103)脑膜瘤可通过标准 MRI 序列识别。MRI 单独的敏感性为 95%(95%CI 0.78, 0.99),特异性为 88%(95%CI 0.58, 0.98)。基于对比剂摄取强度,97 例脑膜瘤可诊断为强烈摄取(93.75%)。脑膜瘤 < 0.5cm 的敏感性最低,为 74%,脑膜瘤 > 2cm 的敏感性最高,为 95%,脑膜瘤 0.5-1.0cm 的敏感性最高,为 100%。岩斜脑膜瘤的敏感性最低,为 88%,蝶骨脑膜瘤为 94%,眶内脑膜瘤为 100%。MRI 诊断脑膜瘤的特异性较高,蝶骨和半球形硬脑膜脑膜瘤以及 0.5-1.0cm 和 1.0-2.0cm 的脑膜瘤特异性均为 100%。总的来说,与 PET/MRI 相比,MRI 能够可靠地检测脑膜瘤。PET/MRI 成像对小或位置困难的脑膜瘤具有最高的敏感性和特异性。